about
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunitiesLaunching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculatureEpidermal growth factor receptor inhibition modulates the microenvironment by vascular normalization to improve chemotherapy and radiotherapy efficacyDeveloping and applying a gene functional association network for anti-angiogenic kinase inhibitor activity assessment in an angiogenesis co-culture model.Portal thrombosis and steatosis after preoperative chemotherapy with FOLFIRI-bevacizumab for colorectal liver metastases.Exploring the role of mitochondrial UQCRB in angiogenesis using small molecules.Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials.Baicalin attenuates laser-induced choroidal neovascularization.Antiangiogenic activity of the lipophilic antimicrobial peptides from an endophytic bacterial strain isolated from red pepper leaf.Tumor-Endothelial Cell Three-dimensional Spheroids: New Aspects to Enhance Radiation and Drug TherapeuticsVEGF/VEGFR signalling as a target for inhibiting angiogenesis.Three-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model.High sensitivity: high-resolution SPECT-CT/MR molecular imaging of angiogenesis in the Vx2 modelAngiogenesis and hypertension: an update.Daphnetin inhibits TNF-α and VEGF-induced angiogenesis through inhibition of the IKKs/IκBα/NF-κB, Src/FAK/ERK1/2 and Akt signalling pathways.Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).Blood coagulation parameters after intravitreal injection of aflibercept in patients with neovascular age-related macular degeneration.Rapidly acting antitumoral antiangiogenic therapies.
P2860
Q26828930-2E72AD1F-34F0-4F03-B57C-1A7029080D65Q28475128-3B279DF8-09E8-44D7-AB46-412A81112A02Q28475894-CA6CBC94-5C13-4E02-BC60-15B174C225A6Q33339727-0ED56CD6-C52B-4615-8B19-8F03EA475F41Q33909734-193BF139-EC9E-4B20-924E-D3A1F81A7D47Q34332044-2B3CBBFD-6D98-4761-B5A9-C5C3632A077BQ35049227-3B903BC4-4293-4757-AF7A-513EF690191EQ35087363-C171A65A-F566-42A7-A9E3-3CA68B89E6A7Q35188518-992F59C7-ED01-416A-A495-586001CE92BBQ35626527-5B0FF4B4-7847-48E1-8382-3756478FF34EQ36677407-DAB8C6A3-46B5-4398-A1FE-1F95A9D20E7FQ37039058-837313B9-D9C3-47AB-BC4D-756BAB670C70Q37245368-8D00FD3A-8558-467E-9942-8107F21EBAE4Q37579043-BD5BFBF2-4C6F-4BD5-8ADF-AF21DD3149E6Q39686369-A46DF07C-3F6B-4D21-BC49-0E6AB01109E0Q46092379-4CF5D042-B7BA-4E99-991A-D11BA9FD759AQ50062366-85182C21-20D9-4F49-A237-7DCDE6617F02Q53522407-0A3616F8-279A-4D4F-AD1B-25F26AC90417
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Update on angiogenesis inhibitors.
@ast
Update on angiogenesis inhibitors.
@en
type
label
Update on angiogenesis inhibitors.
@ast
Update on angiogenesis inhibitors.
@en
prefLabel
Update on angiogenesis inhibitors.
@ast
Update on angiogenesis inhibitors.
@en
P1476
Update on angiogenesis inhibitors.
@en
P2093
Anaadriana Zakarija
Gerald Soff
P304
P356
10.1097/01.CCO.0000183672.15133.AB
P577
2005-11-01T00:00:00Z